On MRKR call, they said that the pancreatic trial has demonstrated some “very exciting clinical results” even though the product they used is not target optimized. And the clinical trial has enrolled/is enrolling rapidly as a result.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.